000 | 01876 a2200493 4500 | ||
---|---|---|---|
005 | 20250517035935.0 | ||
264 | 0 | _c20160822 | |
008 | 201608s 0 0 eng d | ||
022 | _a1873-569X | ||
024 | 7 |
_a10.1016/j.jdermsci.2015.06.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHung, Chih-Tsung | |
245 | 0 | 0 |
_aThe inhibitory mechanism by curcumin on the Zac1-enhanced cyclin D1 expression in human keratinocytes. _h[electronic resource] |
260 |
_bJournal of dermatological science _cSep 2015 |
||
300 |
_a262-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aCell Cycle Proteins _xdrug effects |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aCyclin D1 _xgenetics |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xmetabolism |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKeratinocytes |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xdrug effects |
650 | 0 | 4 |
_aS Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
650 | 0 | 4 |
_aTranscription Factors _xdrug effects |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xdrug effects |
700 | 1 | _aHuang, Shih-Ming | |
700 | 1 | _aCheng, Hsiao-Chun | |
700 | 1 | _aLiu, Shu-Ting | |
700 | 1 | _aChang, Yung-Lung | |
700 | 1 | _aLiu, Ying-Chun | |
700 | 1 | _aWang, Wei-Ming | |
773 | 0 |
_tJournal of dermatological science _gvol. 79 _gno. 3 _gp. 262-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jdermsci.2015.06.006 _zAvailable from publisher's website |
999 |
_c25000931 _d25000931 |